Additionally, the NLRP3 inflammasome has been linked to the development of myeloid leukemias, such as chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), and AML, particularly in the context of KRAS mutations [60,61,62]. Here, NLRP3 is linked to acute myeloid leukemia.